$OMER
OMEROS CORP

2020 Q4 Form 10-K Financial Statement

#000155837021002177 Filed on March 01, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 2019 Q4
Revenue $10.63M $73.81M $33.42M
YoY Change -68.18% -33.98% 51.78%
Cost Of Revenue $90.00K $902.0K $400.0K
YoY Change -77.5% 4.28% 150.0%
Gross Profit $10.55M $72.91M $33.02M
YoY Change -68.05% -34.28% 51.05%
Gross Profit Margin 99.23% 98.78% 98.81%
Selling, General & Admin $17.90M $72.70M $16.13M
YoY Change 10.97% 12.54% 8.33%
% of Gross Profit 169.67% 99.71% 48.85%
Research & Development $26.46M $107.6M $40.59M
YoY Change -34.81% 1.21% 59.49%
% of Gross Profit 250.81% 147.59% 122.93%
Depreciation & Amortization $400.0K $1.620M $530.0K
YoY Change -24.53% -9.5% 70.97%
% of Gross Profit 3.79% 2.22% 1.61%
Operating Expenses $44.36M $107.6M $56.72M
YoY Change -21.79% 1.21% 40.08%
Operating Profit -$33.82M -$156.9M -$23.70M
YoY Change 42.66% 7.45% 28.31%
Interest Expense -$7.990M $26.75M -$5.810M
YoY Change 37.52% 18.07% 12.82%
% of Operating Profit
Other Income/Expense, Net $370.0K $654.0K $290.0K
YoY Change 27.59% -57.89% 93.33%
Pretax Income -$41.43M -$196.4M -$29.23M
YoY Change 41.74% 17.5% -19.83%
Income Tax -$4.160M -$23.30M
% Of Pretax Income
Net Earnings -$37.27M -$138.1M -$29.23M
YoY Change 27.54% 63.41% 24.18%
Net Earnings / Revenue -350.57% -187.04% -87.46%
Basic Earnings Per Share -$2.41
Diluted Earnings Per Share -$604.4K -$2.41 -$577.4K
COMMON SHARES
Basic Shares Outstanding 61.65M 57.18M 49.75M
Diluted Shares Outstanding 57.18M

Balance Sheet

Concept 2020 Q4 2020 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.0M $135.0M $60.80M
YoY Change 122.04% 122.04% 0.5%
Cash & Equivalents $10.50M $10.50M $3.100M
Short-Term Investments $124.5M $124.5M $57.70M
Other Short-Term Assets $11.10M $11.10M $6.600M
YoY Change 68.18% 68.18% 1.54%
Inventory $1.355M $1.400M $1.147M
Prepaid Expenses
Receivables $3.800M $3.800M $35.10M
Other Receivables $70.00K $0.00 $111.0K
Total Short-Term Assets $151.3M $151.3M $103.7M
YoY Change 45.82% 45.9% 15.44%
LONG-TERM ASSETS
Property, Plant & Equipment $28.10M $28.10M $3.829M
YoY Change 633.87% -9.06% -0.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.700M $1.700M $2.300M
YoY Change -26.09% -26.09% 4.55%
Total Long-Term Assets $29.76M $29.70M $33.22M
YoY Change -10.44% -10.81% 447.44%
TOTAL ASSETS
Total Short-Term Assets $151.3M $151.3M $103.7M
Total Long-Term Assets $29.76M $29.70M $33.22M
Total Assets $181.0M $181.0M $137.0M
YoY Change 32.18% 32.12% 42.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.199M $4.200M $5.328M
YoY Change -21.19% -20.75% -15.17%
Accrued Expenses $28.76M $31.50M $46.63M
YoY Change -38.33% -35.58% 54.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.000M $1.000M $1.200M
YoY Change -16.67% -16.67% 34.98%
Total Short-Term Liabilities $36.74M $36.70M $55.46M
YoY Change -33.76% -33.87% 48.46%
LONG-TERM LIABILITIES
Long-Term Debt $237.0M $237.0M $159.8M
YoY Change 48.31% 48.31% 6.11%
Other Long-Term Liabilities $28.00M $28.00M $30.80M
YoY Change -9.09% -9.09% 275.61%
Total Long-Term Liabilities $265.0M $265.0M $190.6M
YoY Change 39.03% 39.03% 20.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.74M $36.70M $55.46M
Total Long-Term Liabilities $265.0M $265.0M $190.6M
Total Liabilities $301.8M $301.8M $246.0M
YoY Change 22.68% 22.68% 25.45%
SHAREHOLDERS EQUITY
Retained Earnings -$872.7M -$734.6M
YoY Change 18.79% 13.0%
Common Stock $751.9M $625.6M
YoY Change 20.19% 13.75%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$120.8M -$120.8M -$109.0M
YoY Change
Total Liabilities & Shareholders Equity $181.0M $181.0M $137.0M
YoY Change 32.18% 32.12% 42.77%

Cashflow Statement

Concept 2020 Q4 2020 2019 Q4
OPERATING ACTIVITIES
Net Income -$37.27M -$138.1M -$29.23M
YoY Change 27.54% 63.41% 24.18%
Depreciation, Depletion And Amortization $400.0K $1.620M $530.0K
YoY Change -24.53% -9.5% 70.97%
Cash From Operating Activities -$18.41M -$100.1M -$23.01M
YoY Change -19.99% 66.61% -6.69%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $283.0K -$10.00K
YoY Change -100.0% -15.27% -90.0%
Acquisitions
YoY Change
Other Investing Activities $7.990M -$66.75M -$39.23M
YoY Change -120.37% 2074.27% 1628.19%
Cash From Investing Activities $8.000M -$67.03M -$39.24M
YoY Change -120.39% 1870.92% 1562.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $93.68M $54.20M
YoY Change 72.71%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -170.0K 174.5M 56.48M
YoY Change -100.3% 187.55% 87.7%
NET CHANGE
Cash From Operating Activities -18.41M -100.1M -23.01M
Cash From Investing Activities 8.000M -67.03M -39.24M
Cash From Financing Activities -170.0K 174.5M 56.48M
Net Change In Cash -10.58M 7.417M -5.770M
YoY Change 83.36% -367.09% -287.95%
FREE CASH FLOW
Cash From Operating Activities -$18.41M -$100.1M -$23.01M
Capital Expenditures $0.00 $283.0K -$10.00K
Free Cash Flow -$18.41M -$100.4M -$23.00M
YoY Change -19.96% 66.15% -6.35%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2020Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNonCurrent
CY2020Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNonCurrent
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001285819
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2018 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2019 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3816000
CY2020 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
us-gaap:ProductMember
CY2019Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2019Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020Q1 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductMember
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54200810
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
61671231
CY2020 omer Period Chargebacks Are Settled
PeriodChargebacksAreSettled
P28D
CY2019Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityCurrent
CY2019Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNonCurrent
CY2019Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
omer:OperatingAndFinanceLeaseLiabilityNonCurrent
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-34475
CY2020 dei Entity Registrant Name
EntityRegistrantName
OMEROS CORPORATION
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WA
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1663741
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
201 Elliott Avenue West
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98119
CY2020 dei City Area Code
CityAreaCode
206
CY2020 dei Local Phone Number
LocalPhoneNumber
676-5000
CY2020 dei Security12b Title
Security12bTitle
Common Stock
CY2020 dei Trading Symbol
TradingSymbol
OMER
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
762308158
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61933806
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10501000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3084000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
124452000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
57704000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3841000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35185000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1355000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1147000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11136000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6625000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
151285000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
103745000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2551000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3829000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25526000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27082000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1055000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1154000
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
625000
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
1159000
CY2020Q4 us-gaap Assets
Assets
181042000
CY2019Q4 us-gaap Assets
Assets
136969000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4199000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5328000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28755000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46627000
CY2020Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
3782000
CY2019Q4 omer Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
3504000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36736000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
55459000
CY2020Q4 omer Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
28770000
CY2019Q4 omer Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
32318000
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
236288000
CY2019Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
158213000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
61671231
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54200810
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
616000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
542000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
751304000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
625048000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-872672000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-734611000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120752000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109021000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
181042000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136969000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73813000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
111805000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29868000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
902000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
865000
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
512000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
110817000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
109696000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
89860000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
72695000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64626000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51718000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
184414000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
175187000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
142090000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-110601000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-63382000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-112222000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13374000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12993000
CY2020 us-gaap Interest Expense
InterestExpense
26751000
CY2019 us-gaap Interest Expense
InterestExpense
22657000
CY2018 us-gaap Interest Expense
InterestExpense
16252000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
654000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1553000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1781000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-150072000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-84486000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-139686000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12011000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12929000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-138061000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-126757000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-138061000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-84486000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-126757000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.41
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.71
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.61
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
57176743
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
49523444
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7598000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
13785000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5022000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-84486000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-109021000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
93675000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48582636
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-2814000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6732000
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1424000
CY2018 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
11713000
CY2018 omer Adjustments To Additional Paid In Capital For Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalForPurchaseOfCappedCalls
33180000
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
55655000
CY2018 omer Adjustments To Additional Paid In Capital For Tax Benefit Related To Issuance Of Convertible Senior Debt Net Of Extinguishment
AdjustmentsToAdditionalPaidInCapitalForTaxBenefitRelatedToIssuanceOfConvertibleSeniorDebtNetOfExtinguishment
12929000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-126757000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-100156000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
54238000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
155000
CY2020 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
14770000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
61628000
CY2020 omer Adjustments To Additional Paid In Capital For Purchase Of Capped Calls
AdjustmentsToAdditionalPaidInCapitalForPurchaseOfCappedCalls
23223000
CY2020 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-22073000
CY2020 omer Adjustments To Additional Paid In Capital For Termination Capped Call Contracts
AdjustmentsToAdditionalPaidInCapitalForTerminationCappedCallContracts
8387000
CY2020 omer Adjustments To Additional Paid In Capital For Tax Benefit Related To Issuance Of Convertible Senior Debt Net Of Extinguishment
AdjustmentsToAdditionalPaidInCapitalForTaxBenefitRelatedToIssuanceOfConvertibleSeniorDebtNetOfExtinguishment
12011000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-138061000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-120752000
CY2020 us-gaap Profit Loss
ProfitLoss
-138061000
CY2019 us-gaap Profit Loss
ProfitLoss
-84486000
CY2018 us-gaap Profit Loss
ProfitLoss
-126757000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
14925000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
13785000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
11713000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11649000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
9232000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5635000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1616000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1790000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
962000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-13374000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12993000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12011000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12929000
CY2020 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-838000
CY2018 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-354000
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-31344000
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
12367000
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5674000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
208000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
567000
CY2020 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
133194000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1059000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-355000
CY2019 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
58217000
CY2018 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
68782000
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
66446000
CY2019 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
55150000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
251000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
498000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-19736000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13283000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10109000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-100086000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60073000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-103737000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
283000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
334000
CY2018 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
94500000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67031000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3401000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
25151000
CY2020 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
225030000
CY2018 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
210000000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6785000
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6800000
CY2018 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
44550000
CY2020 omer Payment For Purchase Of Capped Call
PaymentForPurchaseOfCappedCall
23223000
CY2018 omer Payment For Purchase Of Capped Call
PaymentForPurchaseOfCappedCall
33180000
CY2020 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
125638000
CY2018 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
132077000
CY2018 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
11902000
CY2020 omer Proceeds From Termination Of Capped Call Contracts
ProceedsFromTerminationOfCappedCallContracts
7549000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
93675000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54238000
CY2020 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
5022000
CY2019 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
7598000
CY2018 omer Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
6732000
CY2020 omer Increase Decrease In Restricted Investments
IncreaseDecreaseInRestrictedInvestments
-99000
CY2018 omer Increase Decrease In Restricted Investments
IncreaseDecreaseInRestrictedInvestments
-4681000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1195000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1139000
CY2018 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
951000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
174534000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60697000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81053000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7417000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2777000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2467000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3084000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5861000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3394000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10501000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3084000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5861000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
11603000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
13462000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
8896000
CY2020 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
216000
CY2019 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1440000
CY2018 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
2118000
CY2018 omer Noncash Transaction Conversion Of Accrued Interest Into Notes Payable
NoncashTransactionConversionOfAccruedInterestIntoNotesPayable
3408000
CY2018 omer Warrants Issued
WarrantsIssued
1424000
CY2020 us-gaap Nature Of Operations
NatureOfOperations
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 10.8pt;">Organization</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;">We are a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system, and immune-related diseases, including cancers. Our first drug product, OMIDRIA, is marketed in the United States (U.S.) for use during cataract surgery or intraocular lens replacement.</p>
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;margin:0pt 0pt 12pt 10.8pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:18pt;margin:0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant items subject to such estimates include revenue recognition, stock-based compensation expense, and accruals for clinical trials and manufacturing of drug product. We base our estimates on historical experience and on various other factors, including the impact of the COVID-19 pandemic, that we believe are reasonable under the circumstances; however, actual results could differ from these estimates.</p>
CY2020 omer Maximum Period Product Allowed For Return
MaximumPeriodProductAllowedForReturn
P12M
CY2020 us-gaap Advertising Expense
AdvertisingExpense
5600000
CY2019 us-gaap Advertising Expense
AdvertisingExpense
8000000.0
CY2018 us-gaap Advertising Expense
AdvertisingExpense
2500000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1596124
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2680994
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2873193
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
3771000
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
35074000
CY2020Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
70000
CY2019Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
111000
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3841000
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
35185000
CY2020Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1200000
CY2019Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
1600000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10500000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3100000
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
109000
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
91000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
462000
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
338000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
784000
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
718000
CY2020Q4 us-gaap Inventory Net
InventoryNet
1355000
CY2019Q4 us-gaap Inventory Net
InventoryNet
1147000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10198000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9864000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
7647000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
6035000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
2551000
CY2019Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
3829000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1600000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1800000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1000000.0
CY2020Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
7952000
CY2019Q4 omer Accrued Contract Research Costs
AccruedContractResearchCosts
24107000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5393000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3610000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
5205000
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1640000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3948000
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3546000
CY2020Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
3326000
CY2019Q4 omer Accrued Sales Rebates Fees And Discounts Current
AccruedSalesRebatesFeesAndDiscountsCurrent
10870000
CY2020Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
2121000
CY2019Q4 omer Accrued Clinical Trial Costs
AccruedClinicalTrialCosts
1982000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
810000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
872000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
28755000
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46627000
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
320030000
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
77645000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1367000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6097000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
236288000
CY2020 omer Number Of Options To Extend Lease
NumberOfOptionsToExtendLease
2
CY2020 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
true
CY2020Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
25526000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27082000
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1822000
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
2973000
CY2020Q4 omer Lease Right Of Use Asset
LeaseRightOfUseAsset
27348000
CY2019Q4 omer Lease Right Of Use Asset
LeaseRightOfUseAsset
30055000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2740000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2282000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1042000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1222000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28032000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30772000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
738000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1546000
CY2020Q4 omer Lease Liability
LeaseLiability
32552000
CY2019Q4 omer Lease Liability
LeaseLiability
35822000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y9M18D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y9M18D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1285
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1285
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1185
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.1217
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
6055000
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
4604000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1340000
CY2020 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
295000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
337000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
2893000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
2320000
CY2020 us-gaap Sublease Income
SubleaseIncome
1300000
CY2019 us-gaap Sublease Income
SubleaseIncome
913000
CY2020 us-gaap Lease Cost
LeaseCost
9310000
CY2019 us-gaap Lease Cost
LeaseCost
7688000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
10103000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
6951000
CY2020 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
295000
CY2019 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
337000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1195000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1139000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6536000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1205000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6678000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
603000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6823000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
168000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6972000
CY2020Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
30000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6998000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
12593000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
46600000
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2006000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15828000
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
226000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
30772000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
1780000
CY2020Q4 omer Lessee Operating Lease Liability To Be Paid Monthly
LesseeOperatingLeaseLiabilityToBePaidMonthly
100000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14925000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13785000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11713000
CY2020Q4 omer Long Term Purchase Commitment Termination Fee
LongTermPurchaseCommitmentTerminationFee
32000000.0
CY2020 omer Payment Of Technology Access Fees
PaymentOfTechnologyAccessFees
5500000
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16271227
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
6900000
CY2020Q3 us-gaap Share Price
SharePrice
14.50
CY2020Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
93700000
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4400000
CY2019Q4 us-gaap Share Price
SharePrice
13.10
CY2019Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
54200000
CY2018 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11207931
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.72
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2237535
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.29
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
556421
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.03
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
950517
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.14
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11938528
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.92
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
32384000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
11584202
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
11.88
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
31880000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8805571
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.48
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
27844000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-10149000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-11261000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1862000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1668000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12011000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12929000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12011000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12929000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12000000.0
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12900000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
149993000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
126794000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
56103000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
40654000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
10586000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9959000
CY2020Q4 omer Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
8646000
CY2019Q4 omer Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
7908000
CY2020Q4 omer Deferred Tax Asset Disallowed Interest
DeferredTaxAssetDisallowedInterest
11859000
CY2019Q4 omer Deferred Tax Asset Disallowed Interest
DeferredTaxAssetDisallowedInterest
8122000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7411000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
6433000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
244598000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
199870000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
113000
CY2020Q4 omer Deferred Tax Liabilities Equity Component Of Convertible Debt
DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt
18302000
CY2019Q4 omer Deferred Tax Liabilities Equity Component Of Convertible Debt
DeferredTaxLiabilitiesEquityComponentOfConvertibleDebt
11082000
CY2020Q4 omer Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6197000
CY2019Q4 omer Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
6480000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24612000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
17562000
CY2020Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
219986000
CY2019Q4 omer Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
182308000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
219986000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
182308000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 omer Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
409000000.0
CY2020Q4 omer Operating Loss Carryforwards With No Expiration
OperatingLossCarryforwardsWithNoExpiration
144500000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
37800000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
23900000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.031
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.027
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.025
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.251
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.283
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.189
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.080
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.059
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.046
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.010
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.013
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.080
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.093
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.040
CY2020 omer Defined Contribution Plan Maximum Employer Matching Contribution
DefinedContributionPlanMaximumEmployerMatchingContribution
4000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23537000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13530000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26114000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10632000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
47214000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
41210000
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
51542000
CY2020Q4 us-gaap Costs And Expenses
CostsAndExpenses
44448000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23677000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27680000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25428000
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-33816000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-29031000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-33294000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-38463000
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-37273000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.53
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21779000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26753000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
29856000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33417000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
41018000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
36091000
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
40957000
CY2019Q4 us-gaap Costs And Expenses
CostsAndExpenses
57121000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19239000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-9338000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11101000
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-23704000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-24345000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-14453000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-16463000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-29225000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.50
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.58

Files In Submission

Name View Source Status
0001558370-21-002177-index-headers.html Edgar Link pending
0001558370-21-002177-index.html Edgar Link pending
0001558370-21-002177.txt Edgar Link pending
0001558370-21-002177-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
omer-20201231.xsd Edgar Link pending
omer-20201231x10k.htm Edgar Link pending
omer-20201231x10k006.jpg Edgar Link pending
omer-20201231x10k008.jpg Edgar Link pending
omer-20201231x10k_htm.xml Edgar Link completed
omer-20201231xex10d11.htm Edgar Link pending
omer-20201231xex10d23.htm Edgar Link pending
omer-20201231xex10d24.htm Edgar Link pending
omer-20201231xex1d1.htm Edgar Link pending
omer-20201231xex23d1.htm Edgar Link pending
omer-20201231xex31d1.htm Edgar Link pending
omer-20201231xex31d2.htm Edgar Link pending
omer-20201231xex32d1.htm Edgar Link pending
omer-20201231xex32d2.htm Edgar Link pending
omer-20201231xex4d1.htm Edgar Link pending
omer-20201231xex5d1.htm Edgar Link pending
omer-20201231_cal.xml Edgar Link unprocessable
omer-20201231_def.xml Edgar Link unprocessable
omer-20201231_lab.xml Edgar Link unprocessable
omer-20201231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending